PharmaEngine Announces the Lancet Publication of the ONIVYDE Phase 3 NAPOLI-1 Study

By: via Benzinga
PharmaEngine announced that The Lancet has published the manuscript entitled "Nanoliposomal irinotecan with fluorouracil and leucovorin ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.